newsfilter
← Latest News
GlobeNewswire·

Exagen to Announce Second Quarter Financial Results on August 4, 2026

  • Exagen Inc. (NASDAQ: XGN) will release Q2 2026 financial results before market opens on Tuesday, August 4, 2026.
  • CEO John Aballi & CFO Jeff Black will host a conference call at 8:30 a.m. ET (5:30 a.m. PT) to review results.
  • U.S. dial-in for the call is 877-407-0890; international dial-in is +1 201-389-0918.
  • A live webcast will be available via investors.exagen.com.
  • A telephone replay will be accessible until Tuesday, August 18, 2026, using U.S. number 877-660-6853 or international +1 201-612-7415 with passcode 13760979.
  • A webcast recording will be posted on the Exagen Investor Relations website one hour after the call concludes.
  • Exagen is a San Diego-based provider of autoimmune diagnostics specializing in tests like AVISE® CTD for conditions such as lupus, rheumatoid arthritis, & Sjögren's disease.
  • The company operates a CLIA-certified, CAP-accredited laboratory focused on rheumatic disease testing.
  • Tina Jacobsen, CFA, serves as the contact for investor relations at ir@exagen.com.